Cutaneous T-cell lymphoma and atopy: is there an association?

被引:35
|
作者
Mehrany, K [1 ]
El-Azhary, RA [1 ]
Bouwhuis, SA [1 ]
Pittelkow, MR [1 ]
机构
[1] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA
关键词
atopic dermatitis; cutaneous T-cell lymphoma; mycosis fungoides; Sezary syndrome;
D O I
10.1111/j.1365-2133.2003.05551.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Case reports have suggested a relationship between atopic diatheses and Sezary syndrome, pre-Sezary syndrome or mycosis fungoides. However, Sezary and pre-Sezary syndromes are rare entities, and this association has never been analysed in greater detail for specific subtypes of cutaneous T-cell lymphoma (CTCL). Objectives To evaluate the prevalence of atopy in subjects with Sezary syndrome, pre-Sezary syndrome or mycosis fungoides, and to compare the rates with the reported prevalence of atopy in the general population. Methods We retrospectively reviewed the records of 157 patients with the diagnosis of Sezary or pre-Sezary syndrome seen between 1965 and 2000, and 102 patients with the diagnosis of mycosis fungoides evaluated from 1994 to 2000 at Mayo Clinic. Results Of 157 subjects with Sezary or pre-Sezary syndrome and 102 subjects with mycosis fungoides, 18 and 12, respectively, were identified as having a history of atopic dermatitis, asthma or allergic rhinitis. The prevalence rates of atopy in Sezary or pre-Sezary syndrome and mycosis fungoides were 11.5% (95% confidence interval 6.9-17.5%) and 11.8% (6.2-19.7%), respectively. Conclusions No significant difference exists in the prevalence of atopy in Sezary or pre-Sezary syndrome compared with that in mycosis fungoides (chi(2)-test, P = 1.00). Furthermore, the rates of atopy in Sezary or pre-Sezary syndrome and mycosis fungoides are not significantly different from the prevalence of atopy in the general population (17-40%). On the basis of these observations, no evidence currently implicates a causal association of CTCL with atopy.
引用
收藏
页码:1013 / 1017
页数:5
相关论文
共 50 条
  • [1] Cutaneous T-cell Lymphoma
    Lansigan, Frederick
    Choi, Jaehyuk
    Foss, Francine M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 979 - +
  • [2] Cutaneous T-cell lymphoma
    Kotz, EA
    Anderson, D
    Thierst, BH
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (02) : 131 - 137
  • [3] Cutaneous T-cell Lymphoma
    Weiner, David M.
    Rook, Alain H.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (05) : 1087 - 1110
  • [4] Decoupling the association of dupilumab with cutaneous T-cell lymphoma
    Neubauer, Zachary J. K.
    Brunner, Patrick M.
    Geskin, Larisa J.
    Guttman, Emma
    Lipner, Shari R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1296 - 1298
  • [5] Phototherapy for Cutaneous T-Cell Lymphoma
    Marka, Arthur
    Carter, Joi B.
    DERMATOLOGIC CLINICS, 2020, 38 (01) : 127 - +
  • [6] Management of cutaneous T-cell lymphoma
    Duhovic, Chris
    Child, Fiona
    Wain, E. Mary
    CLINICAL MEDICINE, 2012, 12 (02) : 160 - 164
  • [7] Cutaneous T-cell Lymphoma
    Pulitzer, Melissa
    CLINICS IN LABORATORY MEDICINE, 2017, 37 (03) : 527 - +
  • [8] Infectious agents in cutaneous T-cell lymphoma
    Mirvish, Ezra D.
    Pomerantz, Rebecca G.
    Geskin, Larisa J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : 423 - 431
  • [9] Update on treatment of cutaneous T-cell lymphoma
    Gardner, Jennifer M.
    Evans, Katherine G.
    Musiek, Amy
    Rook, Alain H.
    Kim, Ellen J.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 131 - 137
  • [10] Forodesine in the treatment of cutaneous T-cell lymphoma
    Lewis, Daniel J.
    Duvic, Madeleine
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 771 - 775